Novo Nordisk CEO Targets Longevity and Aesthetics Beyond Weight Loss
Novo Nordisk's CEO has outlined a strategic pivot beyond the GLP-1 weight-loss franchise into longevity science and medical aesthetics, per Bloomberg. The shift carries direct dermatology implication…